Literature DB >> 30576259

The Need for Policy Change Regarding Progestin-Only Injectable Contraceptives.

Erica L Gollub1, Heidi E Jones2, Lauren J Ralph3, Janneke H H M van de Wijgert4,5, Nancy Padian6, Zena Stein7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30576259      PMCID： PMC6909683          DOI： 10.1089/jwh.2018.7284

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN： 1540-9996            Impact factor:   3.017


× No keyword cloud information.
  25 in total

1.  Return of fertility in women discontinuing injectable contraceptives.

Authors:  K Fotherby; G Howard
Journal:  J Obstet Gynaecol (Lahore)       Date:  1986-04

Review 2.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

3.  Lessons learnt from the introduction of the contraceptive implant in South Africa

Authors:  M Pleaner; C Morroni; J Smit; N Lince-Deroche; M Chersich; S Mullick; D Pillay; M Makua; H Rees
Journal:  S Afr Med J       Date:  2017-10-01

4.  Progesterone implants enhance SIV vaginal transmission and early virus load.

Authors:  P A Marx; A I Spira; A Gettie; P J Dailey; R S Veazey; A A Lackner; C J Mahoney; C J Miller; L E Claypool; D D Ho; N J Alexander
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

Review 5.  Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data.

Authors:  Lauren J Ralph; Erica L Gollub; Heidi E Jones
Journal:  Curr Opin Obstet Gynecol       Date:  2015-12       Impact factor: 1.927

6.  Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.

Authors:  Irina A Zalenskaya; Neelima Chandra; Nazita Yousefieh; Xi Fang; Oluwatosin E Adedipe; Suzanne S Jackson; Sharon M Anderson; Christine K Mauck; Jill L Schwartz; Andrea R Thurman; Gustavo F Doncel
Journal:  J Clin Invest       Date:  2018-09-17       Impact factor: 14.808

7.  Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.

Authors:  Charles S Morrison; Pai-Lien Chen; Cynthia Kwok; Jared M Baeten; Joelle Brown; Angela M Crook; Lut Van Damme; Sinead Delany-Moretlwe; Suzanna C Francis; Barbara A Friedland; Richard J Hayes; Renee Heffron; Saidi Kapiga; Quarraisha Abdool Karim; Stephanie Karpoff; Rupert Kaul; R Scott McClelland; Sheena McCormack; Nuala McGrath; Landon Myer; Helen Rees; Ariane van der Straten; Deborah Watson-Jones; Janneke H H M van de Wijgert; Randy Stalter; Nicola Low
Journal:  PLoS Med       Date:  2015-01-22       Impact factor: 11.069

8.  A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use.

Authors:  Evelyne Kestelyn; Stephen Agaba; Jennifer Ilo Van Nuil; Mireille Uwineza; Marie Michelle Umulisa; Lambert Mwambarangwe; Jean Claude Ndagijimana; Irith De Baetselier; Jozefien Buyze; Thérèse Delvaux; Tania Crucitti; Vicky Jespers; Janneke H H M van de Wijgert
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

9.  Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk.

Authors:  Ailsa R Butler; Jennifer A Smith; Chelsea B Polis; Simon Gregson; David Stanton; Timothy B Hallett
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

Review 10.  An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.

Authors:  Chelsea B Polis; Kathryn M Curtis; Philip C Hannaford; Sharon J Phillips; Tsungai Chipato; James N Kiarie; Daniel J Westreich; Petrus S Steyn
Journal:  AIDS       Date:  2016-11-13       Impact factor: 4.177
View more
  2 in total

1.  Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity.

Authors:  Xiangxu Jia; Qiujia Shao; Ahsen R Chaudhry; Ballington L Kinlock; Michael G Izban; Hong-Ying Zhang; Fernando Villalta; James E K Hildreth; Bindong Liu
Journal:  Pathogens       Date:  2021-09-14

2.  Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.

Authors:  Janet P Hapgood
Journal:  AIDS Res Hum Retroviruses       Date:  2020-01-22       Impact factor: 2.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.